Deutsches Krebsforschungszentrum (DKFZ)

NMR-based diffusion lattice imaging (2016) Laun FB, Mueller L, Kuder TA Journal article A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis (2016) Miehlke S, Hruz P, Vieth M, Bussmann C, Von Arnim U, Bajbouj M, Schlag C, et al. Journal article Fast and noninvasive characterization of suspicious lesions detected at breast cancer X-ray screening: Capability of diffusion-weighted MR imaging with MIPs (2016) Bickelhaupt S, Tesdorff J, Lederer W, Daniel H, Stieber A, Delorme S, Schlemmer HP, Laun FB Journal article Selected clinically established and scientific techniques of diffusion-weighted MRI: In the context of imaging in oncology Ausgewählte klinisch etablierte und wissenschaftliche Techniken der diffusionsgewichteten MRT: Im Kontext der onkologischen Bildgebung (2016) Freitag MT, Bickelhaupt S, Ziener C, Meier-Hein K, Radtke JP, Mosebach J, Kuder TA, et al. Journal article Chemotherapy for intracranial ependymoma in adults (2016) Gramatzki D, Roth P, Felsberg J, Hofer S, Rushing EJ, Hentschel B, Westphal M, et al. Journal article Conventions and nomenclature for double diffusion encoding NMR and MRI (2016) Shemesh N, Jespersen SN, Alexander DC, Cohen Y, Drobnjak I, Dyrby TB, Finsterbusch J, et al. Journal article, Review article COMBINED ALTERATIONS IN MAPK PATHWAY GENES, CDKN2A/B AND ATRX CHARACTERIZE ANAPLASTIC PILOCYTIC ASTROCYTOMA (2016) Kratz A, Sahm F, Schrimpf D, Jones DT, Reuss D, Koelsche C, Huang K, et al. Conference contribution Transcriptional Targeting of Mature Dendritic Cells with Adenoviral Vectors via a Modular Promoter System for Antigen Expression and Functional Manipulation (2016) Knippertz I, Deinzer A, Dörrie J, Schaft N, Nettelbeck DM, Steinkasserer A Journal article Outcome on 560 metastatic melanoma (MM) patients treated with pembrolizumab during the German Expanded Access Program (EAP) (2016) Hassel J, Forschner A, Bluhm L, Heinzerling L, Zimmer L, Utikal J, Kaehler K, et al. Conference contribution Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab (2016) Weide B, Martens A, Hassel JC, Berking C, Postow MA, Bisschop K, Simeone E, et al. Journal article